First Commerical Pancreas Treatment In Spain
Filed with ASX · · 2 pages · English
commercial treatment with the OncoSil device has now been performed in the region; ✓ The treatment was delivered at The Hospital Universitario de Fuenlabrada in Madrid, Spain; ✓ Ten hospitals in Spain have been trained in the use of the OncoSil device; and ✓ The OSPREY Patient registry has been granted ethics approval at all of these treatment sites. Sydney, Australia – 13 April 2022: OncoSil Medi
Earlier from OncoSil Medical
- Fully-Funded Trial Approved In Germany
- Half Yearly Report Results
- OncoSil approved for Innovation Funding (NUB) in Germany
- PanCO Clinical Study on OncoSil Published in ESMO Open
- 2021 AGM CEO Presentation
Later from OncoSil Medical
- OncoSil Signs Commercial Agreement With Hospital In Spain
- OncoSil Launches $10m Capital Raising
- Clarification Of Non-Renouncable Entitlement Offer Details
- OncoSil Entitlement Offer Booklet
- Entitlement Offer Results and Shortfall Notification
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical